Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series.

Rhapsido (remibrutinib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42697489

Duoqin Wang; Hui Tang; Lin Xie; Maorui Yi; Sunyi Chen; Wenli Zhang; Yanyun Shen; Yiqi Zhu

Sep 5, 2026